The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.
As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
19hon MSN
In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...
Only two in five people taking GLP-1 medication were confident they would maintain their weight loss after stopping the ...
“I love Thanksgiving for the pumpkin pie — it's such a low-sugar dessert that it tends to be fine for your blood sugar,” ...
6hon MSN
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...
A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...
The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at the ...
Here's what doctors thing is behind personality changes caused by Ozempic and other GLP-1s and what you can do about it.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback